[Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
D000328:Adult; D000368:Aged; D000641:Ammonia / Q000097:blood; D001927:Brain Diseases / Q000188:drug therapy*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004187:Disaccharides / Q000627:therapeutic use*; D004569:Electroencephalography; D005260:Female; D006801:Humans; D007792:Lactulose / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000150:complications; D008297:Male; D008875:Middle Aged; D009461:Neurologic Manifestations; D010919:Placebos; D011167:Portacaval Shunt, Surgical / Q000009:adverse effects*
D004187:Disaccharides; D010919:Placebos; D007792:Lactulose; D000641:Ammonia
Etude en double aveugle du lactulose chez 18 malades atteints d'encéphalopathie hépatique chronique aprés shunt porto-cave.